$RDGT

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results

Ridgetech, Inc. (Nasdaq: RDGT) reported fiscal year 2026 results for the year ended March 31, 2026. Revenue rose 10.2% to $132.16 million, driven by a full year of Allright’s online platform after its Feb. 28, 2025 acquisition. Gross profit increased 23.8% to $4.75 million, but net loss was $1.25 million versus net income $10.20 million a year earlier.

Original reporting
Published Jul 31, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 1:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RDGT
Neutral
medium confidence
Mentioned
$RDGT
Relevance
7/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$RDGTNeutralMed
01

Why it matters

Traders will likely focus on whether the Allright-driven online mix can lift gross margin above the current 3.6% level and whether the offline credit-sales risk mitigation stabilizes cash flows.

02

Market read

FY2026 results show revenue growth and improved gross profit, but continued net loss and very low gross margin, with offline revenue pressured by credit-sales discontinuation.

03

What to watch

Offline wholesale revenue fell due to discontinued credit sales after delayed repayments, which could reduce future bad-debt risk but also suppress top-line growth.

Relevance 7/10Novelty 7/10Timing: pre-market today (FY2026 results released July 31, 2026)

Background

Ridgetech is a China healthcare product distributor that completed a strategic transition to a wholesale-focused model via acquisition of Allright and divestiture of its retail drugstore business.

Company-level read

Ticker impact

$RDGTNeutralMedium confidence
Context

Ridgetech reported FY2026 results, including revenue up 10.2% to $132.16M and shifting to a wholesale-focused model after acquiring Allright.

Expected impact

Near-term volatility likely as traders weigh revenue growth versus continued low gross margin (3.6%) and net loss of $1.25M.

Evidence & confidence

The release provides concrete financial datapoints (revenue, gross margin, net loss) and explains the offline credit-sales risk mitigation that reduced offline revenue.

Market effects

Highlights execution risk in China pharmaceutical distribution economics, with gross margin staying low even after mix shift to online.

China healthcare distribution demand and e-commerce channel adoption remain key drivers for small-cap distributors.

Limited, as the company is China-focused and the disclosure is primarily company-specific.

Counterpoint

The large online revenue jump is largely accounting timing from a full year of Allright, so the underlying profitability trend may be improving but not yet reflected in gross margin.

Key entities

  • Ridgetech, Inc.

    Nasdaq-listed wholesale distributor of pharmaceutical and healthcare products in China; reported FY2026 financial results and business-model transition.

  • Allright (Hangzhou) Internet Technology Co. Ltd

    Online and offline wholesale distributor acquired in Feb 2025; its full-year contribution drove FY2026 online revenue growth.

Related articles

$RDGTMed

Ridgetech Inc. (RDGT): Financial results for FY2026

Ridgetech Inc. (RDGT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) (“Ridgetech” or the “Company”), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced

$CHEMed

Chemed outlines 12- to 18-month integration timeline for $62.5M California Roto-Rooter franchise buyback while expecting 2026 EPS at or slightly above prior high end (NYSE:CHE)

Chemed (CHE) announced a 12- to 18-month integration timeline for its $62.5M California Roto-Rooter franchise buyback. CEO Kevin McNamara reported VITAS revenue grew 12.2% year-over-year, driven by ADC growth and cost containment. The company expects 2026 EPS to be at or slightly above the prior high end.